Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $62.5700 (-2.92%) ($62.5700 - $62.5700) on Thu. Dec. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.3% (three month average) | RSI | 87 | Latest Price | $62.5700(-2.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.4% a day on average for past five trading days. | Weekly Trend | EDIT advances 39.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(62%) IWO(58%) ARKG(55%) IWC(55%) IBUY(54%) | Factors Impacting EDIT price | EDIT will decline at least -3.15% in a week (0% probabilities). VIXM(-29%) UUP(-15%) VXX(-12%) TBT(-7%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.15% (StdDev 6.3%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $63.16(-0.93%) | 10 Day Moving Average | $55.65(12.43%) | 20 Day Moving Average | $43.52(43.77%) | To recent high | -6.5% | To recent low | 131% | Market Cap | $3.886b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |